Stock listing
NASDAQ:TELO Telomir Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Telomir Pharmaceuticals, Inc.
Follow Telomir Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TELO
$0.915 USD -0.020 (-2.1%)
Close on Nov 2, 2026
- Day range
- $0.907 – $0.960 USDNov 2, 2026
- Volume
- 58,043 sharesNov 2, 2026
- Market cap
- $67.42M USDAt the close on Nov 2, 2026 · price × 73.68M shares outstanding
- 52-week range
- $0.791 – $1.580 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $96,902 USDMedian day 53,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TELO · Home | $0.915 USD | -0.020 (-2.1%) | 58,043 | $0.940 | $0.960 | $0.907 | $0.935 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:TELO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.915 | -0.020 | -2.1% | $0.940 | $0.960 | $0.907 | 58,043 | |
| $0.935 | -0.029 | -3.0% | $0.960 | $0.990 | $0.791 | 96,698 | |
| $0.964 | -0.046 | -4.5% | $0.980 | $1.010 | $0.962 | 115,058 | |
| $1.010 | -0.010 | -1.0% | $1.000 | $1.050 | $0.980 | 44,535 | |
| $1.020 | +0.021 | +2.2% | $1.030 | $1.070 | $1.010 | 53,982 | |
| $0.999 | +0.024 | +2.4% | $1.000 | $1.045 | $0.975 | 41,887 | |
| $0.975 | -0.035 | -3.5% | $0.980 | $0.990 | $0.960 | 48,800 | |
| $1.010 | -0.010 | -1.0% | $1.030 | $1.030 | $0.970 | 93,400 | |
| $1.020 | +0.010 | +1.0% | $1.010 | $1.060 | $1.010 | 37,700 | |
| $1.010 | -0.030 | -2.9% | $1.020 | $1.050 | $1.000 | 78,000 | |
| $1.040 | -0.010 | -1.0% | $1.050 | $1.099 | $1.030 | 29,200 | |
| $1.050 | 0.000 | 0.0% | $1.040 | $1.130 | $1.040 | 39,200 | |
| $1.050 | 0.000 | 0.0% | $1.040 | $1.070 | $1.010 | 69,300 | |
| $1.050 | -0.040 | -3.7% | $1.100 | $1.105 | $1.030 | 86,900 | |
| $1.090 | -0.010 | -0.9% | $1.100 | $1.200 | $1.075 | 53,800 | |
| $1.100 | -0.020 | -1.8% | $1.130 | $1.140 | $1.090 | 70,900 | |
| $1.120 | -0.030 | -2.6% | $1.160 | $1.160 | $1.100 | 64,600 | |
| $1.150 | +0.030 | +2.7% | $1.110 | $1.150 | $1.100 | 131,500 | |
| $1.120 | -0.080 | -6.7% | $1.160 | $1.170 | $1.120 | 124,500 | |
| $1.200 | -0.010 | -0.8% | $1.250 | $1.580 | $1.170 | 1,253,700 | |
| $1.210 | +0.030 | +2.5% | $1.240 | $1.270 | $1.190 | 134,400 | |
| $1.180 | +0.010 | +0.9% | $1.170 | $1.220 | $1.170 | 74,100 | |
| $1.170 | -0.030 | -2.5% | $1.200 | $1.220 | $1.150 | 59,700 | |
| $1.200 | +0.030 | +2.6% | $1.190 | $1.240 | $1.170 | 43,300 | |
| $1.170 | -0.030 | -2.5% | $1.190 | $1.200 | $1.160 | 34,300 | |
| $1.200 | -0.030 | -2.4% | $1.235 | $1.235 | $1.170 | 72,100 | |
| $1.230 | +0.020 | +1.7% | $1.220 | $1.230 | $1.200 | 56,000 | |
| $1.210 | -0.010 | -0.8% | $1.210 | $1.240 | $1.210 | 31,100 | |
| $1.220 | -0.030 | -2.4% | $1.240 | $1.245 | $1.210 | 34,600 | |
| $1.250 | +0.010 | +0.8% | $1.250 | $1.290 | $1.210 | 103,200 | |
| $1.240 | +0.010 | +0.8% | $1.230 | $1.245 | $1.190 | 46,400 | |
| $1.230 | +0.110 | +9.8% | $1.150 | $1.300 | $1.130 | 480,500 | |
| $1.120 | -0.010 | -0.9% | $1.180 | $1.240 | $1.100 | 146,400 | |
| $1.130 | -0.040 | -3.4% | $1.144 | $1.169 | $1.130 | 37,700 | |
| $1.170 | 0.000 | 0.0% | $1.160 | $1.179 | $1.140 | 27,200 | |
| $1.170 | 0.000 | 0.0% | $1.120 | $1.198 | $1.115 | 50,000 | |
| $1.170 | -0.010 | -0.8% | $1.180 | $1.208 | $1.110 | 33,100 | |
| $1.180 | -0.040 | -3.3% | $1.190 | $1.220 | $1.175 | 32,500 | |
| $1.220 | +0.030 | +2.5% | $1.190 | $1.230 | $1.180 | 32,100 | |
| $1.190 | +0.030 | +2.6% | $1.140 | $1.230 | $1.130 | 74,900 | |
| $1.160 | 0.000 | 0.0% | $1.170 | $1.190 | $1.160 | 33,900 | |
| $1.160 | +0.040 | +3.6% | $1.120 | $1.170 | $1.110 | 64,200 | |
| $1.120 | +0.020 | +1.8% | $1.110 | $1.130 | $1.089 | 31,400 | |
| $1.100 | -0.020 | -1.8% | $1.130 | $1.130 | $1.085 | 19,600 | |
| $1.120 | -0.020 | -1.8% | $1.110 | $1.140 | $1.080 | 45,400 | |
| $1.140 | -0.050 | -4.2% | $1.200 | $1.200 | $1.140 | 38,200 | |
| $1.190 | +0.020 | +1.7% | $1.160 | $1.200 | $1.145 | 130,200 | |
| $1.170 | -0.010 | -0.8% | $1.170 | $1.200 | $1.141 | 69,000 | |
| $1.180 | +0.010 | +0.9% | $1.180 | $1.196 | $1.156 | 40,500 | |
| $1.170 | +0.040 | +3.5% | $1.130 | $1.200 | $1.130 | 56,400 | |
| $1.130 | 0.000 | 0.0% | $1.130 | $1.160 | $1.110 | 43,300 | |
| $1.130 | -0.040 | -3.4% | $1.180 | $1.180 | $1.110 | 35,300 | |
| $1.170 | +0.090 | +8.3% | $1.100 | $1.200 | $1.100 | 100,800 | |
| $1.080 | +0.020 | +1.9% | $1.050 | $1.085 | $1.031 | 28,500 | |
| $1.060 | -0.030 | -2.8% | $1.100 | $1.110 | $1.050 | 48,200 | |
| $1.090 | +0.040 | +3.8% | $1.050 | $1.135 | $1.050 | 58,400 | |
| $1.050 | -0.060 | -5.4% | $1.090 | $1.100 | $1.040 | 86,700 | |
| $1.110 | -0.020 | -1.8% | $1.140 | $1.140 | $1.075 | 52,600 | |
| $1.130 | -0.040 | -3.4% | $1.170 | $1.181 | $1.130 | 27,578 | |
| $1.170 | +0.010 | +0.9% | $1.160 | $1.190 | $1.150 | 36,831 | |
| $1.160 | -0.010 | -0.9% | $1.170 | $1.170 | $1.160 | 11,400 | |
| $1.170 | -0.010 | -0.8% | $1.190 | $1.205 | $1.155 | 19,300 | |
| $1.180 | +0.030 | +2.6% | $1.150 | $1.185 | $1.130 | 74,800 | |
| $1.150 | -0.090 | -7.3% | $1.250 | $1.250 | $1.150 | 81,700 | |
| $1.240 | +0.030 | +2.5% | $1.200 | $1.250 | $1.200 | 54,900 |
- Ticker
- NASDAQ:TELO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 25 slides
Latest news
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
Oct 6, 2026
Closed $1.20 (-0.8%) on Oct 6, 2026
Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
Sep 17, 2026
Closed $1.12 (-0.9%) on Sep 17, 2026
Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
Sep 14, 2026
Closed $1.17 (0.0%) on Sep 14, 2026
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
Aug 10, 2026
Closed $1.17 (+0.9%) on Aug 10, 2026
Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model
Jun 15, 2026
Closed $1.29 (+2.4%) on Jun 15, 2026
Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease
May 20, 2026
Closed $1.31 (+7.4%) on May 20, 2026
Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer
Apr 30, 2026
Closed $1.40 (-3.4%) on Apr 30, 2026
Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1
Apr 27, 2026
Closed $1.42 (+1.4%) on Apr 27, 2026
Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)
Apr 24, 2026
Closed $1.40 (+1.4%) on Apr 24, 2026
Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models
Feb 17, 2026
Closed $1.15 (+5.5%) on Feb 17, 2026
Financings
Private placement of common stock
Oct 6, 2026
Announced: about US$5.6M · US$1.16 a share · Alexander Capital, L.P.
Dealers: Alexander Capital, L.P. (lead)
Buyers: John Paul DeJoria (additional $1.0 million investment)
Use of proceeds: Clinical development of Telomir-Zn, including its Phase 1/2 program in advanced or metastatic TNBC, plus working capital and general corporate purposes
Decks
Investor Presentation (July 2026)
Investor deck · 25 slides · July 2026
Investor Presentation (April 2026)
Investor deck · 43 slides · April 2026
Corporate Update (April 2024)
Corporate update · 31 slides · Apr 15, 2024
Telomir Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 57 in all · newest Oct 6, 2026 · oldest 2024
- Decks
- 3 decks · latest July 2026
Where Telomir Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TELO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TELO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Telomir Pharmaceuticals, Inc.